Telavancin activity tested against Gram-positive clinical isolates from European, Russian and Israeli hospitals (2011–2013) using a revised broth microdilution testing method: redefining the baseline activity of telavancin-Reference-Cited by-同舟云学术

Telavancin activity tested against Gram-positive clinical isolates from European, Russian and Israeli hospitals (2011–2013) using a revised broth microdilution testing method: redefining the baseline activity of telavancin

Published:2016-03-03 Issue:2 Volume:28 Page:83-88
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Mendes Rodrigo E.,Flamm Robert K.,Farrell David J.,Sader Helio S.,Jones Ronald N.

Publisher

Maney Publishing

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference21 articles.

1. Comparative Surveillance Study of Telavancin Activity against Recently Collected Gram-Positive Clinical Isolates from across the United States

2. In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative

3. Update on the telavancin activity tested against European staphylococcal clinical isolates (2009–2010)

4. Further Insights into the Mode of Action of the Lipoglycopeptide Telavancin through Global Gene Expression Studies

5. Activity of Telavancin against Staphylococci and Enterococci Determined by MIC and Resistance Selection Studies

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial Activity of Telavancin Tested In Vitro Against a Global Collection of Gram-Positive Pathogens, Including Multidrug-Resistant Isolates (2015–2017);Microbial Drug Resistance;2020-08-01

2. Regional analysis of telavancin and comparator antimicrobial activity against multidrug-resistant Staphylococcus aureus collected in the USA 2014–2016;Journal of Global Antimicrobial Resistance;2020-03

3. 42936 pathogens from Canadian hospitals: 10 years of results (2007–16) from the CANWARD surveillance study;Journal of Antimicrobial Chemotherapy;2019-08-01

4. Comparative Pharmacodynamics of Telavancin and Vancomycin in the Neutropenic Murine Thigh and Lung Infection Models against Staphylococcus aureus;Antimicrobial Agents and Chemotherapy;2017-07

5. Efficacy of Telavancin Alone and in Combination with Ampicillin in a Rat Model of Enterococcus faecalis Endocarditis;Antimicrobial Agents and Chemotherapy;2017-06